For patients with relapsed, refractory, or recurrent cancer, early phase clinical trials may be a treatment option. Phase I and phase II clinical trials provide access to the newest, most innovative therapies to patients.
The Advancing Childhood Cancer Therapies (ACCT) Clinic is dedicated to
offering state-of-the-art therapies, advancing the science of pediatric
research, and providing personalized care to you and your family. The Clinic includes experts in each type of cancer as well as teams of subspecialists and nurses who are leaders in their respective fields. In August 2016, we joined the Children’s Oncology Group Phase 1 Consortium, one of only 21 such centers in the United States and the only one in New England.
Our currently active phase I and phase II trials for patients with relapsed, recurrent, or refractory cancer are listed below by disease – or search all of our available clinical trials.
If you have questions about which trial might be right for your child or patient, please email us at email@example.com or call us at 1-855-320-2090. We can help you navigate your options.
Contact usNot sure which clinical trials might be right for your child? Email our clinical trials team at firstname.lastname@example.org.
U.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.
Precision cancer medicine provides individualized treatment tailored to the specific genetic characteristics of a patient's cancer. Our research and clinical trials are leading the way in precision medicine for pediatric cancer.